Cargando…

HLA3D: an integrated structure-based computational toolkit for immunotherapy

MOTIVATION: The human major histocompatibility complex (MHC), also known as human leukocyte antigen (HLA), plays an important role in the adaptive immune system by presenting non-self-peptides to T cell receptors. The MHC region has been shown to be associated with a variety of diseases, including a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingyu, Lin, Xue, Mei, Xueyin, Chen, Pin, Liu, Anna, Liang, Weicheng, Chang, Shan, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116210/
https://www.ncbi.nlm.nih.gov/pubmed/35289353
http://dx.doi.org/10.1093/bib/bbac076
_version_ 1784710070621175808
author Li, Xingyu
Lin, Xue
Mei, Xueyin
Chen, Pin
Liu, Anna
Liang, Weicheng
Chang, Shan
Li, Jian
author_facet Li, Xingyu
Lin, Xue
Mei, Xueyin
Chen, Pin
Liu, Anna
Liang, Weicheng
Chang, Shan
Li, Jian
author_sort Li, Xingyu
collection PubMed
description MOTIVATION: The human major histocompatibility complex (MHC), also known as human leukocyte antigen (HLA), plays an important role in the adaptive immune system by presenting non-self-peptides to T cell receptors. The MHC region has been shown to be associated with a variety of diseases, including autoimmune diseases, organ transplantation and tumours. However, structural analytic tools of HLA are still sparse compared to the number of identified HLA alleles, which hinders the disclosure of its pathogenic mechanism. RESULT: To provide an integrative analysis of HLA, we first collected 1296 amino acid sequences, 256 protein data bank structures, 120 000 frequency data of HLA alleles in different populations, 73 000 publications and 39 000 disease-associated single nucleotide polymorphism sites, as well as 212 modelled HLA heterodimer structures. Then, we put forward two new strategies for building up a toolkit for transplantation and tumour immunotherapy, designing risk alignment pipeline and antigenic peptide prediction pipeline by integrating different resources and bioinformatic tools. By integrating 100 000 calculated HLA conformation difference and online tools, risk alignment pipeline provides users with the functions of structural alignment, sequence alignment, residue visualization and risk report generation of mismatched HLA molecules. For tumour antigen prediction, we first predicted 370 000 immunogenic peptides based on the affinity between peptides and MHC to generate the neoantigen catalogue for 11 common tumours. We then designed an antigenic peptide prediction pipeline to provide the functions of mutation prediction, peptide prediction, immunogenicity assessment and docking simulation. We also present a case study of hepatitis B virus mutations associated with liver cancer that demonstrates the high legitimacy of our antigenic peptide prediction process. HLA3D, including different HLA analytic tools and the prediction pipelines, is available at http://www.hla3d.cn/.
format Online
Article
Text
id pubmed-9116210
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91162102022-05-19 HLA3D: an integrated structure-based computational toolkit for immunotherapy Li, Xingyu Lin, Xue Mei, Xueyin Chen, Pin Liu, Anna Liang, Weicheng Chang, Shan Li, Jian Brief Bioinform Problem Solving Protocol MOTIVATION: The human major histocompatibility complex (MHC), also known as human leukocyte antigen (HLA), plays an important role in the adaptive immune system by presenting non-self-peptides to T cell receptors. The MHC region has been shown to be associated with a variety of diseases, including autoimmune diseases, organ transplantation and tumours. However, structural analytic tools of HLA are still sparse compared to the number of identified HLA alleles, which hinders the disclosure of its pathogenic mechanism. RESULT: To provide an integrative analysis of HLA, we first collected 1296 amino acid sequences, 256 protein data bank structures, 120 000 frequency data of HLA alleles in different populations, 73 000 publications and 39 000 disease-associated single nucleotide polymorphism sites, as well as 212 modelled HLA heterodimer structures. Then, we put forward two new strategies for building up a toolkit for transplantation and tumour immunotherapy, designing risk alignment pipeline and antigenic peptide prediction pipeline by integrating different resources and bioinformatic tools. By integrating 100 000 calculated HLA conformation difference and online tools, risk alignment pipeline provides users with the functions of structural alignment, sequence alignment, residue visualization and risk report generation of mismatched HLA molecules. For tumour antigen prediction, we first predicted 370 000 immunogenic peptides based on the affinity between peptides and MHC to generate the neoantigen catalogue for 11 common tumours. We then designed an antigenic peptide prediction pipeline to provide the functions of mutation prediction, peptide prediction, immunogenicity assessment and docking simulation. We also present a case study of hepatitis B virus mutations associated with liver cancer that demonstrates the high legitimacy of our antigenic peptide prediction process. HLA3D, including different HLA analytic tools and the prediction pipelines, is available at http://www.hla3d.cn/. Oxford University Press 2022-03-14 /pmc/articles/PMC9116210/ /pubmed/35289353 http://dx.doi.org/10.1093/bib/bbac076 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Problem Solving Protocol
Li, Xingyu
Lin, Xue
Mei, Xueyin
Chen, Pin
Liu, Anna
Liang, Weicheng
Chang, Shan
Li, Jian
HLA3D: an integrated structure-based computational toolkit for immunotherapy
title HLA3D: an integrated structure-based computational toolkit for immunotherapy
title_full HLA3D: an integrated structure-based computational toolkit for immunotherapy
title_fullStr HLA3D: an integrated structure-based computational toolkit for immunotherapy
title_full_unstemmed HLA3D: an integrated structure-based computational toolkit for immunotherapy
title_short HLA3D: an integrated structure-based computational toolkit for immunotherapy
title_sort hla3d: an integrated structure-based computational toolkit for immunotherapy
topic Problem Solving Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116210/
https://www.ncbi.nlm.nih.gov/pubmed/35289353
http://dx.doi.org/10.1093/bib/bbac076
work_keys_str_mv AT lixingyu hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT linxue hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT meixueyin hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT chenpin hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT liuanna hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT liangweicheng hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT changshan hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy
AT lijian hla3danintegratedstructurebasedcomputationaltoolkitforimmunotherapy